FindTrial
Sign In

Clinical Study for the Reconstruction of First Phase Insulin Secretion in Newly Diagnosed Type 2 Diabetes Mellitus

Clinical Study for the Reconstruction of First Phase Insulin Secretion in Newly Diagnosed Type 2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028665
Enrollment
Unknown
Registered
2019-12-29
Start date
2008-01-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

LGI group:Hypoglycemia index diet
MGI group:Moderate glycemic index diet
HGI group:Hyperglycemia index diet

Sponsors

Hai'nan General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. diagnosed type 2 diabetes mellitus patients (according to who 1999 standard); 2. fasting blood glucose < 10 mmol / L; 3. glycosylated hemoglobin < 9%; 4. never received oral lipid-lowering drugs, hypoglycemic drugs or insulin treatment.

Exclusion criteria

Exclusion criteria: 1. type 1 diabetes, gestational diabetes and special type diabetes; 2. acute complications of diabetes, such as diabetic ketoacidosis, hyperglycemia and hypertonic state; 3. heart, liver and kidney dysfunction; 4. acute infectious diseases; 5. type 2 diabetes patients who have received oral lipid-lowering drugs, hypoglycemic drugs or pancreatic islet hormone treatment.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose;2h postprandial glucose;HbAlc;Insulin;—

Secondary

MeasureTime frame
blood lipids;C-reactive protein;weight;—

Countries

China

Contacts

Public ContactChen Kaining

Hainan General Hospital

kainch@sina.com+86 0898 68622223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026